Iyoshi Shohei, Sunohara Mayuko, Yoshihara Masato, Kunishima Atsushi, Miyamoto Emiri, Fujimoto Hiroki, Kitami Kazuhisa, Mogi Kazumasa, Uno Kaname, Yoshida Kosuke, Tamauchi Satoshi, Yokoi Akira, Niimi Kaoru, Yoshikawa Nobuhisa, Emoto Ryo, Matsui Shigeyuki, Kajiyama Hiroaki
Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
Institute for Advanced Research, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.
Jpn J Clin Oncol. 2025 Jul 6;55(7):743-750. doi: 10.1093/jjco/hyaf046.
In ovarian cancer (OvCa), achieving complete resection (RO) in initial surgery is crucial for improving prognosis. However, patients with undetected microscopic metastasis post-RO surgery often have poorer outcomes. This study explores prognostic factors for OvCa patients who underwent RO surgery, focusing on the role of ascites cytology as an indicator of microscopic peritoneal metastasis.
We analyzed data from 975 OvCa cases in the Tokai Ovarian Tumor Study Group database (1986-2019). Excluding patients without chemotherapy or with distant metastasis, we examined prognostic factors using Cox regression analysis. Propensity score (PS) methods balanced the cytology-positive and -negative groups, with subgroup analysis for clinical stage and ascites volume.
Multivariate analysis identified FIGO stage III and positive ascites cytology as poor prognostic factors for overall and progression-free survival. After PS adjustment, positive ascites cytology also shortened progression-free intervals post-recurrence, especially in cases with peritoneal or lymph node metastasis. Subgroup analysis revealed a more substantial prognostic impact of positive ascites cytology in early-stage cases.
The present results suggest that in OvCa patients with the R0 status, the presence of tumor cells in ascites is an independent negative prognostic factor and may be an indicator of peritoneal micro-metastasis.
在卵巢癌(OvCa)中,初次手术实现完全切除(RO)对于改善预后至关重要。然而,RO手术后未检测到微小转移的患者往往预后较差。本研究探讨接受RO手术的OvCa患者的预后因素,重点关注腹水细胞学作为微小腹膜转移指标的作用。
我们分析了东海卵巢肿瘤研究组数据库(1986 - 2019年)中975例OvCa病例的数据。排除未接受化疗或有远处转移的患者,我们使用Cox回归分析检查预后因素。倾向评分(PS)方法平衡了细胞学阳性和阴性组,并对临床分期和腹水量进行了亚组分析。
多变量分析确定国际妇产科联盟(FIGO)III期和腹水细胞学阳性是总体生存和无进展生存的不良预后因素。经过PS调整后,腹水细胞学阳性也缩短了复发后的无进展间期,尤其是在有腹膜或淋巴结转移的病例中。亚组分析显示,腹水细胞学阳性在早期病例中的预后影响更大。
目前的结果表明,在处于R0状态的OvCa患者中,腹水中存在肿瘤细胞是一个独立的负面预后因素,可能是腹膜微转移的一个指标。